Show simple item record

dc.contributor.authorLydon, S
dc.contributor.authorGarvey, E
dc.date.accessioned2012-09-19T13:45:12Z
dc.date.available2012-09-19T13:45:12Z
dc.date.issued2008
dc.identifier.urihttp://hdl.handle.net/10147/245002
dc.description.abstractThe aim was to assess whether the established advantages of pharmacist conducted medication reconciliation, applies to oncology and haematology inpatients
dc.language.isoenen
dc.publisherMidland Regional Hospital, Tullamoreen_GB
dc.subjectINPATIENT SERVICESen_GB
dc.subjectONCOLOGYen_GB
dc.subjectPHARMACISTen_GB
dc.subjectHAEMATOLOGYen_GB
dc.subjectMEDICATION MANAGEMENTen_GB
dc.titleMedication reconciliation in oncology & haematology inpatientsen_GB
dc.contributor.departmentMidland Regional Hospital, Arden Road, Tullamore, Co. Offalyen_GB
dc.description.provinceLeinsteren
refterms.dateFOA2018-08-22T22:29:17Z
html.description.abstractThe aim was to assess whether the established advantages of pharmacist conducted medication reconciliation, applies to oncology and haematology inpatients


Files in this item

Thumbnail
Name:
SLMedicationReconciliationinOH ...
Size:
180.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record